Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 1,759.00
+39.50 (2.30%)
Apr 27, 2026, 3:29 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 130.5 billion as of April 27, 2026. Its market cap has decreased by -16.59% in one year.
Market Cap
130.50B
Enterprise Value
121.52B
Revenue
20.92B
Ranking
n/a
PE Ratio
21.26
Stock Price
1,759.00
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 130.50B, an increase of 2,330,685.50%. That is a compound annual growth rate of 51.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 134.04B | -4.23% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 228.33B |
| Piramal Pharma | 219.72B |
| NATCO Pharma | 195.80B |
| Eris Lifesciences | 190.29B |
| Alembic Pharmaceuticals | 147.63B |
| Cohance Lifesciences | 137.76B |
| Alivus Life Sciences | 128.88B |
| Strides Pharma Science | 98.28B |